Friday, March 27, 2026 For Patients CME Credits Newsletters
Subscribe

Pediatrics

3 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Oral Sucrose Fails to Reduce Pain in Preterm Infants During Lung Ultrasound
In a RCT with 60 preterm infants, oral sucrose plus pacifier did not reduce pain vs. pacifier alone during LUS (p=0.16).
Researchers studied if giving sugar water and a pacifier could help reduce pain in preterm infants during lung scans. They found that using just a pacifier was just as effective as using both sugar wa…
Ondansetron Slightly Prolongs QTc Interval in Pediatrics Without Dysrhythmia Risk
Meta-analysis shows ondansetron increases QTc by 4.7 ms (95% CI 1.4-8.1) in healthy children, with no dysrhythmia risk.
Researchers looked at how ondansetron affects heart rhythms in healthy children. They found that while there were small changes in heart measurements, these did not lead to any heart rhythm problems.…
Predictors of Saccadic Reaction Time in Zambian Children: Birth Spacing, Nutrition, and Diarrhea Impact
In a study of 299 children in Lusaka, Zambia, factors like being the only child <5, baseline LAZ, dietary diversity, and recent diarrhea significantly predicted saccadic reaction time (SRT). SRT was n…
Researchers studied how quickly young children in Zambia can process visual information. They found that being the only child, eating a variety of foods, and recent illness can influence this speed.…
CT.gov · Phase 3 Trial Evaluates Safety and Immunogenicity of CHIKV VLP Vaccine in Childr… CT.gov · Phase 2 Study: L-SABR Plus Standard Therapy in Metastatic NSCLC Patients CT.gov · Ivonescimab Phase II Study Targets 55% DCR in Relapsed Pleural Mesothelioma CT.gov · Phase 2 Study Evaluates Frexalimab, Brivekimig, Rilzabrutinib in FSGS and MCD CT.gov · Phase 2 Study: ManNAc for FSGS Shows Promise in Reducing Proteinuria CT.gov · Phase 3 Trial: Anifrolumab Shows Promise in SLE with BICLA Response as Primary O…